You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.
Grünenthal integrates sustainability into its core strategy, with patient safety and product quality forming the foundation of its approach. As a global leader in pain management and related diseases, Grünenthal is committed to addressing unmet medical needs by developing innovative treatments that improve patient outcomes and quality of life. Beyond patient wellbeing, Grünenthal’s sustainability goals focus on workforce development, environmental responsibility, and ethical business conduct.
Grünenthal’s Corporate Responsibility Programme integrates sustainability into the core of its business operations. All business areas collaborate cross-functionally to manage environmental, social and governance (ESG) risks and make a net-positive impact through targeted initiatives in the three focus areas Patient, People and Planet.
A cross-functional Corporate Responsibility Board is responsible for implementing, continuously developing and driving the Corporate Responsibility Programme, ensuring consistent oversight at the highest strategic level.
We have identified the most relevant ESG topics for our business and stakeholders. They define the areas in which Grünenthal has the highest impacts, and they span our entire value chain. We cluster them under our focus areas of Patient, People and Planet.
